Cargando…

Biomarkers in Rheumatoid Arthritis

Detalles Bibliográficos
Autores principales:	Goëb, Vincent, Fardellone, Patrice, Sibilia, Jean, Ponchel, Frédérique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100293/ https://www.ncbi.nlm.nih.gov/pubmed/25061261 http://dx.doi.org/10.1155/2014/379310

Ejemplares similares

Bone Remodelling Markers in Rheumatoid Arthritis
por: Fardellone, Patrice, et al.
Publicado: (2014)

Bone Loss, Osteoporosis, and Fractures in Patients with Rheumatoid Arthritis: A Review
por: Fardellone, Patrice, et al.
Publicado: (2020)

Cytokines as Biomarkers in Rheumatoid Arthritis
por: Burska, Agata, et al.
Publicado: (2014)

Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
por: Salomon, Sarah, et al.
Publicado: (2017)

Comparison of Rheumatoid Arthritis Patients’ 2-Year Infliximab, Abatacept, and Tocilizumab Persistence Rates
por: Diep, Laetitia, et al.
Publicado: (2022)

Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis
por: Churchman, Sarah M, et al.
Publicado: (2014)

Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes
por: Goëb, Vincent, et al.
Publicado: (2009)

Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritis
por: Goëb, Vincent, et al.
Publicado: (2005)

Current characteristics of a population of psoriatic arthritis and gender disparities
por: Menis, Jimmy, et al.
Publicado: (2023)

Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives
por: Promelle, Veronique, et al.
Publicado: (2021)

Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach
por: Obry, Antoine, et al.
Publicado: (2014)

Biomarkers for Treatment Response in Rheumatoid Arthritis: Where are they?
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
por: Burska, Agata N., et al.
Publicado: (2014)

DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms
por: Pitaksalee, Rujiraporn, et al.
Publicado: (2023)

Therapeutic Maintenance of Baricitinib and Tofacitinib in Real Life
por: Deprez, Valentine, et al.
Publicado: (2020)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Rheumatoid Arthritis
por: Melchiorre, Daniela, et al.
Publicado: (2013)

Is the Calcium Score Useful for Rheumatoid Arthritis Patients at Low or Intermediate Cardiovascular Risk?
por: Jesson, Claire, et al.
Publicado: (2022)

Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases: Perspectives and therapeutic aspects
por: Harifi, Ghita, et al.
Publicado: (2016)

Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification
por: Paccou, Julien, et al.
Publicado: (2014)

Vasculogenesis in rheumatoid arthritis
por: Szekanecz, Zoltán, et al.
Publicado: (2010)

Rheumatoid Arthritis in Minorities
por: Anaya, Juan-Manuel, et al.
Publicado: (2013)

Atherosclerosis in Rheumatoid Arthritis
por: González-Gay, Miguel A., et al.
Publicado: (2012)

Fatigue in rheumatoid arthritis
por: Choy, Ernest H, et al.
Publicado: (2019)

Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network
por: Salmon, Jean-Hugues, et al.
Publicado: (2020)

Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease-
por: Oyama, Jun-ichi, et al.
Publicado: (2019)

Nutrition and Diet in Rheumatoid Arthritis
por: Cutolo, Maurizio, et al.
Publicado: (2022)

Solid Cancers and Rheumatoid Arthritis
por: Kalliolias, George D., et al.
Publicado: (2023)

Biomarkers in Rheumatoid Arthritis
por: Shapiro, Samantha C
Publicado: (2021)

The persistence of abnormal T-cell differentiation patterns predicts relapse in rheumatoid arthritis patients with controlled disease
por: Brown, A, et al.
Publicado: (2005)

Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk Warnings
por: Philippoteaux, Cécile, et al.
Publicado: (2022)

Understanding IFNλ in rheumatoid arthritis
por: de Groen, Rik A, et al.
Publicado: (2014)

Androgens in rheumatoid arthritis: when are they effectors?
por: Cutolo, Maurizio
Publicado: (2009)

Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
por: Roubenoff, Ronenn
Publicado: (2009)

The regulation of IL-7 production in synovial stromal cells in rheumatoid arthritis is promiscuous
por: Field, S, et al.
Publicado: (2007)

Comparative effect of tumour necrosis factor inhibitors versus other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis
por: Virone, Alexandre, et al.
Publicado: (2019)

Moving towards personalized medicine in rheumatoid arthritis
por: de Jong, Tamarah D, et al.
Publicado: (2014)

Inflammatory cells and bone loss in rheumatoid arthritis
por: Haynes, David R
Publicado: (2007)

Which patients with rheumatoid arthritis are still working?
por: Uhlig, Till
Publicado: (2010)

'Rac'-ing upstream to treat rheumatoid arthritis
por: Firestein, Gary S
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_13tjfq231fign647uha9uts4ii